Venture Capital Access Online | The eMarketplace for the Venture Capital Industry


Bookmark and Share   


Contact Us






Venture Capital Database 2015 Now Available!

Vapotherm Closes $24 Million Series B Financing Round

EXETER, N.H., April 3, 2014-- On March 21, 2014, Vapotherm closed a $24MM financing round. Gilde Healthcare Partners, L.P., led the financing round, which also included new investor Adage Capital Management, L.P. and existing investors 3x5 Special Opportunity Fund, Morgenthaler Ventures, Kaiser Permanente, Integral Capital Partners, QuestMark Partners and Cross Creek Capital.

"We are excited by the Vapotherm opportunity and delighted to join the investor group," said Geoff Pardo, General Partner of Gilde Healthcare Partners, and new member of the Board of Directors. "Vapotherm's proprietary technology has proven to generate superior patient outcomes and lower the cost of care for providers. We look forward to the company growing and improving healthcare for patients world wide."

"We are delighted to have Gilde and Adage join our existing investors. They both have strong track records in supporting growing medical device companies and we appreciate their confidence in our team and our products," said Joe Army, President & CEO.

Vapotherm, Inc. is a privately held manufacturer of advanced respiratory care devices based in Exeter, New Hampshire. The company develops innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 600,000 patients have been treated with Vapotherm high flow therapy. For more information, visit

John Landry, CFO (603) 658-0011

News Index

Venture Capital Database 



Latest VC News
VC News Archive
News Search
RSS News Feed

List Your Firm


Venture Capital Database

VCPro Database
Download Trial
Buy Now

VC Tools

VC Pitch
Private Placement Memorandum

Business Plan Tools

Free Business Plan Template
Business Plan Tools



Copyright 1998-2015 Access InterComm  All rights reserved. 
Site Map | Privacy Statement | Legal Notice & Disclaimer